BioCryst Pharmaceuticals Stock Forecast
Red day on Friday for BioCryst Pharmaceuticals stock after losing 0.670%
(Updated on May 03, 2024)
The BioCryst Pharmaceuticals stock price fell by -0.670% on the last day (Friday, 3rd May 2024) from $4.48 to $4.45. During the last trading day the stock fluctuated 5.66% from a day low at $4.42 to a day high of $4.67. The price has fallen in 7 of the last 10 days but is still up by 0.45% over the past 2 weeks. Volume has increased on the last day by 409 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 million shares were bought and sold for approximately $11.73 million.
The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -24.62% during the next 3 months and, with a 90% probability hold a price between $3.03 and $3.57 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
BCRX Signals & Forecast
There are mixed signals in the stock today. The BioCryst Pharmaceuticals stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $4.73. On a fall, the stock will find some support from the short-term average at $4.32. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. A buy signal was issued from a pivot bottom point on Tuesday, April 30, 2024, and so far it has risen 7.75%. Further rise is indicated until a new top pivot has been found.
Support, Risk & Stop-loss for BioCryst Pharmaceuticals stock
BioCryst Pharmaceuticals finds support from accumulated volume at $4.43 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.250 between high and low, or 5.66%. For the last week, the stock has had daily average volatility of 7.04%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (BCRX) For The Upcoming Trading Day Of Monday 6th
For the upcoming trading day on Monday, 6th we expect BioCryst Pharmaceuticals to open at $4.51, and during the day (based on 14 day Average True Range), to move between $4.18 and $4.72, which gives a possible trading interval of +/-$0.269 (+/-6.05%) up or down from last closing price. If BioCryst Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 12.10% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $4.43 (0.45%) than the resistance at $5.00 (12.36%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
BioCryst Pharmaceuticals will release earnings BMO on Monday, May 06, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.230. We will update the financials statements for BioCryst Pharmaceuticals, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 11.96% in the first trading day after earnings release.
Is BioCryst Pharmaceuticals stock A Buy?
BioCryst Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -3.256 Sell Candidate Unchanged
Predicted Opening Price for BioCryst Pharmaceuticals of Monday, May 6, 2024
| Fair opening price May 6, 2024 | Current price |
|---|---|
| $4.51 ( 1.42%) | $4.45 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for BCRX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 4.76 | 7.04 % | |
| R2 | 4.67 | 4.90 % | ||
| R1 | 4.61 | 3.57 % | ||
| Current price: | 4.45 | |||
| Support | S1 | 4.42 | -0.723 % | |
| S2 | 4.36 | -2.05 % | ||
| S3 | 4.26 | -4.19 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 5.32 | 19.55 % | |
| R2 | 5.14 | 15.51 % | ||
| R1 | 5.00 | 12.36 % | ||
| Current price | 4.45 | |||
| Support | S1 | 4.43 | -0.449% | |
| S2 | 4.38 | -1.57% | ||
| S3 | 4.16 | -6.52% |
FAQ
Click here for our free guide on how to buy BioCryst Pharmaceuticals Stock.
